Please assess the completion status of the following clinical trial:

Trial Title: TAP Block in DIEP or Free MS-TRAM Donor Site: A RCT

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~-Pre-operative eligibility:~* Patients above the age of 18, no upper age limit~* English-speaking~* Delayed reconstruction (mastectomy already performed) or immediate reconstruction (mastectomy at the same time as reconstruction)~* Reconstruction using abdominal tissues including free MS-TRAM or DIEP~Exclusion Criteria:~* Patient refusal~* Inability to give informed consent~* BMI \> 40~* Allergy to Bupivacaine~* Known cardiac or liver disease (contraindicated for Bupivacaine use)~* Patients who will undergo any of the following:~  * Implant breast reconstruction~ * Combined implant and autologous tissue reconstruction~ * Non-abdominally based autologous tissue reconstruction~ * Nonmicrosurgical abdominally based breast reconstruction (pedicled TRAM flap)~* Drug addiction~* Opioid tolerance defined as preoperative opioid use of \>50 mg PO morphine equivalent~* Psychiatric illness

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Isotonic saline (control group) (Type: PLACEBO_COMPARATOR): At the conclusion of the surgery, a 0.2 mL/kg bolus of Saline will be injected through each catheter in the OR. At midnight following the OR, 0.2mL/Kg of Saline will be injected through each catheter every 8 hours for the next 2 postoperative days by a MD member of the pain team. At 8am on postoperative day 3, the TAP catheters were removed by the pain team. Our rationale for decreasing the frequency of intermittent boluses from every 12 hours to 8 hours in this study design was based on our finding in the pilot study that patients frequently used more PCA between 8-12 hours following Bupivacaine bolus as the effect of the anaesthetic agent weaned off.
- Bupivacaine (study group) (Type: EXPERIMENTAL): At the conclusion of the surgery, a 0.2 mL/kg bolus of 0.25% Bupivacaine will be injected through each catheter in the OR. At midnight following the OR, 0.2mL/Kg of 0.25% Bupivacaine will be injected through each catheter every 8 hours for the next 2 postoperative days by a MD member of the pain team. At 8am on postoperative day 3, the TAP catheters were removed by the pain team. Our rationale for decreasing the frequency of intermittent boluses from every 12 hours to 8 hours in this study design was based on our finding in the pilot study that patients frequently used more PCA between 8-12 hours following Bupivacaine bolus as the effect of the anaesthetic agent weaned off.

Based on this trial design, predict the completion outcome and termination type (if applicable).